AEMD Aethlon Medical Corp: Likuiditas cepet

This price chart for Aethlon Medical (AEMD) illustrates the asset's performance, with a value of 4.91. Aethlon Medical is recognized as a leader in extracorporeal blood purification, maintaining a significant presence in critical care medicine. The business develops the Hemopurifier for the mechanical removal of exosomes and viruses in oncology as a complement to pharmaceutical treatments. Production relies on AI-driven manipulators that automatically assemble membranes and verify filter leak-tightness.

Aethlon Medical (AEMD) brings together elite engineers to develop blood filtration systems, which requires stable funding for payroll. This metric measures the company's ability to immediately settle its obligations using only cash and accounts receivable, excluding inventory. It is critical for investors to assess the risk of cash flow gaps and the efficiency of capital utilization. The trend of the quick ratio allows for a precise determination of the business's financial stability.